Close

Amgen (AMGN) Receives FDA Approval for BLINCYTO sBLA in Ph- r/r ALL

Go back to Amgen (AMGN) Receives FDA Approval for BLINCYTO sBLA in Ph- r/r ALL
Amgen Inc (NASDAQ: AMGN) Delayed: 268.93 +6.18 (2.35%)
Previous Close $262.75    52 Week High $176.85 
Open $264.63    52 Week Low $133.64 
Day High $269.38    P/E 40.50 
Day Low $260.68    EPS $6.64 
Volume 3,380,076